Autoimmune pancreatitis – treatment and pitfalls in diagnostics;Autoimmune Pankreatitis – Behandlung und Problematik der Diagnosestellung

Internist

Volumn 55, Issue 10, 2014, Pages 1231-1241

  Rasch, S ^a   Phillip, V ^a   Weirich, G ^a   Esposito, I ^a   Gaa, J ^a   Schmid, R M ^a   Algul H ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Autoimmune diseases; HISORt criteria; Immunoglobulin G; International consensus diagnostic criteria; Pancreatitis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; IMMUNOGLOBULIN G4; RITUXIMAB; ANTIINFLAMMATORY AGENT; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY;

ARTICLE; AUTOIMMUNE PANCREATITIS; CHOLESTASIS; CLINICAL FEATURE; CONSENSUS; CYSTIC FIBROSIS; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; JAUNDICE; LYMPHOCYTIC INFILTRATION; MEDLINE; PAIN; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; PATHOGENESIS; RECURRENT DISEASE; SEROLOGY; STEROID THERAPY; SYSTEMIC DISEASE; TREATMENT RESPONSE; AUTOIMMUNE DISEASES; LABORATORY DIAGNOSIS; PANCREATITIS;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; AUTOIMMUNE DISEASES; AZATHIOPRINE; DIAGNOSIS, DIFFERENTIAL; FALSE POSITIVE REACTIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PANCREATITIS;

EID: 84910142688     PISSN: 00209554     EISSN: 14321289     Source Type: Journal    
DOI: 10.1007/s00108-014-3562-2     Document Type: Article

References (33)

1. Chari ST, Murray JA (2008) Autoimmune pancreatitis, Part II: the relapse. Gastroenterology 134:625–628
2. Chari ST, Smyrk TC, Levy MJ et al (2006) Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol 4:1010–1016, 1934
3. Chari ST, Kloeppel G, Zhang L et al (2010) Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreas 39:549–554
4. Deshpande V, Zen Y, Chan JK et al (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25:1181–1192
5. Detlefsen S, Mohr Drewes A, Vyberg M et al (2009) Diagnosis of autoimmune pancreatitis by core needle biopsy: application of six microscopic criteria. Virchows Arch 454:531–539
6. Detlefsen S, Zamboni G, Frulloni L et al (2012) Clinical features and relapse rates after surgery in type 1 autoimmune pancreatitis differ from type 2: a study of 114 surgically treated European patients. Pancreatology 12:276–283
7. Ghazale A, Chari ST, Smyrk TC et al (2007) Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol 102:1646–1653
8. Hart PA, Topazian MD, Witzig TE et al (2012) Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut 62(11):1607–1615
9. Hirano K, Tada M, Isayama H et al (2007) Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut 56:1719–1724
10. Kamisawa T, Okamoto A (2008) IgG4-related sclerosing disease. World J Gastroenterol 14:3948–3955
11. Kamisawa T, Egawa N, Inokuma S et al (2003) Pancreatic endocrine and exocrine function and salivary gland function in autoimmune pancreatitis before and after steroid therapy. Pancreas 27:235–238
12. Kamisawa T, Shimosegawa T, Okazaki K et al (2009) Standard steroid treatment for autoimmune pancreatitis. Gut 58:1504–1507
13. Kamisawa T, Takuma K, Anjiki H et al (2010) Differentiation of autoimmune pancreatitis from pancreatic cancer by diffusion-weighted MRI. Am J Gastroenterol 105:1870–1875
14. Kamisawa T, Takuma K, Egawa N et al (2010) Autoimmune pancreatitis and IgG4-related sclerosing disease. Nat Rev Gastroenterol Hepatol 7:401–409
15. Kawaguchi K, Koike M, Tsuruta K et al (1991) Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol 22:387–395
16. Khosroshahi A, Carruthers MN, Deshpande V et al (2012) Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine (Baltimore) 91:57–66
17. Lohr JM, Faissner R, Koczan D et al (2010) Autoantibodies against the exocrine pancreas in autoimmune pancreatitis: gene and protein expression profiling and immunoassays identify pancreatic enzymes as a major target of the inflammatory process. Am J Gastroenterol 105:2060–2071
18. Milosavljevic T, Kostic-Milosavljevic M, Jovanovic I et al (2012) Extraintestinal manifestations of autoimmune pancreatitis. Dig Dis 30:220–223
19. Muhi A, Ichikawa T, Motosugi U et al (2012) Mass-forming autoimmune pancreatitis and pancreatic carcinoma: differential diagnosis on the basis of computed tomography and magnetic resonance cholangiopancreatography, and diffusion-weighted imaging findings. J Magn Reson Imaging 35:827–836
20. Notohara K, Burgart LJ, Yadav D et al (2003) Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol 27:1119–1127
21. Okazaki K, Uchida K, Ohana M et al (2000) Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology 118:573–581
22. Okazaki K, Kawa S, Kamisawa T et al (2006) Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol 41:626–631
23. Okazaki K, Tomiyama T, Mitsuyama T et al (2014) Diagnosis and classification of autoimmune pancreatitis. Autoimmun Rev 13:451–458
24. Sah RP, Chari ST, Pannala R et al (2010) Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology 139:140–148, e112–e143
25. Sarles H, Sarles JC, Muratore R, Guien C (1961) Chronic inflammatory sclerosis of the pancreas – an autonomous pancreatic disease? Am J Dig Dis 6:688–698
26. Shimosegawa T, Chari ST, Frulloni L et al (2011) International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 40:352–358
27. Stone JH, Zen Y, Deshpande V (2012) IgG4-related disease. N Engl J Med 366:539–551
28. Sugumar A, Chari ST (2009) Distinguishing pancreatic cancer from autoimmune pancreatitis: a comparison of two strategies. Clin Gastroenterol Hepatol 7:S59–S62
29. Sugumar A, Levy MJ, Kamisawa T et al (2011) Endoscopic retrograde pancreatography criteria to diagnose autoimmune pancreatitis: an international multicentre study. Gut 60:666–670
30. Takuma K, Kamisawa T, Anjiki H et al (2010) Metachronous extrapancreatic lesions in autoimmune pancreatitis. Intern Med 49:529–533
31. Yadav D, Timmons L, Benson JT et al (2011) Incidence, prevalence, and survival of chronic pancreatitis: a population-based study. Am J Gastroenterol 106:2192–2199
32. Yoshida K, Toki F, Takeuchi T et al (1995) Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 40:1561–1568
33. Zamboni G, Luttges J, Capelli P et al (2004) Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch 445:552–563